DZI20-203-Case-5

Sequence	Case	Clinical history	Diagnosis
1	DZI20-203-Case-1 DZI20-203-Case-1	81 yo M with endobronchial mass 81 yo M with endobronchial mass	FX1+level) Calc, f/o bronchus; FX2) bone, bone marrow, cartilage. Query hamartoma vs heterotopic ossification final: hamartoma FX1+level) Calc, f/o bronchus; FX2) bone, bone marrow, cartilage. Query hamartoma vs heterotopic ossification final: hamartoma
2	DZI20-203-Case-2 DZI20-203-Case-2	76 yo M RUL lung nodule 76 yo M RUL lung nodule	Lymphocytes, plasma cells and spindle cells. Infection vs IMT. Negative for carcinoma Final: fibroinflammatory changes and bronchiectasis with necrosis, palisading granulomas and rare giant cells Lymphocytes, plasma cells and spindle cells. Infection vs IMT. Negative for carcinoma Final: fibroinflammatory changes and bronchiectasis with necrosis, palisading granulomas and rare giant cells
3	DZI20-203-Case-3 DZI20-203-Case-3	73 yo M with RLL mass 73 yo M with RLL mass	adenocarcinoma w/ mucinous features Final: invasive mucinous adenocarcinoma adenocarcinoma w/ mucinous features Final: invasive mucinous adenocarcinoma
4	DZI20-203-Case-4 DZI20-203-Case-4	77 yo M with RML mass 77 yo M with RML mass	metastatic RCC final: metastatic RCC metastatic RCC final: metastatic RCC
5	DZI20-203-Case-5 DZI20-203-Case-5	74 yo F with RLL mass 74 yo F with RLL mass	FX1) adenocarcinoma with lepidic, acinar and papillary patterns. FX3)Paranchymal LN = granulomatous inflammation in a nodular pattern Final: adenocarcinoma (50% lepidic, 40% acinar, 10% papillary). Lymph node: granulomatous inflammation FX1) adenocarcinoma with lepidic, acinar and papillary patterns. FX3)Paranchymal LN = granulomatous inflammation in a nodular pattern Final: adenocarcinoma (50% lepidic, 40% acinar, 10% papillary). Lymph node: granulomatous inflammation
6	DZI20-203-Case-6 DZI20-203-Case-6	74 yo M with 2 RUL masses identified grossly. Frozens taken: FX1: Parenchymal margin, FX1A: Mass #1, FX2B: Mass #2 (subpleural) 74 yo M with 2 RUL masses identified grossly. Frozens taken: FX1: Parenchymal margin, FX1A: Mass #1, FX2B: Mass #2 (subpleural)	FX1: Margin negative, FX1A: SCC. FX1B: fibroelastotic scarring Final: SCC, keratinizing. Prominent subpleural fibroelastotic scarring, which may represent prominent apical cap. FX1: Margin negative, FX1A: SCC. FX1B: fibroelastotic scarring Final: SCC, keratinizing. Prominent subpleural fibroelastotic scarring, which may represent prominent apical cap.
7	DZI20-203-Case-7 DZI20-203-Case-7	73 yo M with h/o PDAC now with lung nodule LLL 73 yo M with h/o PDAC now with lung nodule LLL	fibrosis, CI and collections of histiocytes. No tumor seen. Final: fibroinflammatory changes with organization and focal cavity formation fibrosis, CI and collections of histiocytes. No tumor seen. Final: fibroinflammatory changes with organization and focal cavity formation
8	DZI20-203-Case-8 DZI20-203-Case-8	52 yo F with RUL mass 52 yo F with RUL mass	adenocarcinoma final: adenocarcinoma (acinar mod 90%, lepidic 10%) adenocarcinoma final: adenocarcinoma (acinar mod 90%, lepidic 10%)
9	DZI20-203-Case-9 DZI20-203-Case-9	50 yo F with hilar adenopathy 50 yo F with hilar adenopathy	non-necrotizing granulomas in one lymph node and the other extensively hyalinized. Final: non-necrotizing granulomas, c/w sarcoid in the appropriate clinical context non-necrotizing granulomas in one lymph node and the other extensively hyalinized. Final: non-necrotizing granulomas, c/w sarcoid in the appropriate clinical context
10	DZI20-203-Case-10 DZI20-203-Case-10	63 yo M with a RML nodule 63 yo M with a RML nodule	mucinous epithelial proliferation, favor ciliated mucondoular papillary tumor final: ciliated mucondoular papillary tumor mucinous epithelial proliferation, favor ciliated mucondoular papillary tumor final: ciliated mucondoular papillary tumor

12

Page: of 2